Pharma Mar reported EUR40.51M in Sales Revenues for its fiscal quarter ending in December of 2023.

Sales Change Date
Almirall EUR 428.46M 37.6M Dec/2023
Avita Medical AUD 27.84M 5.54M Dec/2023
Ionis Pharmaceuticals USD 325M 180.79M Dec/2023
IQVIA Holdings USD 3.87B 132M Dec/2023
Laboratorios Farma 448.66M 67.82M Dec/2023
Magenta Therapeutics USD 457K 467K Dec/2023
Moderna USD 2.81B 980M Dec/2023
Organon & Co 1.6B 79M Dec/2023
Pharma Mar EUR 40.51M 3.06M Dec/2023
Revvity USD 695.9M 25.16M Dec/2023
Viatris USD 3.84B 104.6M Dec/2023
Xeris Pharmaceuticals USD 44.39M 3.93M Dec/2023